Follow
Antonio Gasbarrini
Antonio Gasbarrini
Professor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, Italy
Verified email at iol.it
Title
Cited by
Cited by
Year
Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report
P Malfertheiner, F MÚgraud, CA O'Morain, JP Gisbert, EJ Kuipers, ...
Gut 66 (1), 6-30, 2017
3800*2017
What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases
E Rinninella, P Raoul, M Cintoni, F Franceschi, GAD Miggiano, ...
Microorganisms 7 (1), 14, 2019
26202019
Statements from the Taormina expert meeting on occult hepatitis B virus infection
G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ...
Journal of hepatology 49 (4), 652-657, 2008
11252008
European consensus conference on faecal microbiota transplantation in clinical practice
G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ...
Gut 66 (4), 569-580, 2017
10962017
Proteobacteria: a common factor in human diseases
G Rizzatti, LR Lopetuso, G Gibiino, C Binda, A Gasbarrini
BioMed research international 2017, 2017
8542017
Commensal Clostridia: leading players in the maintenance of gut homeostasis
LR Lopetuso, F Scaldaferri, V Petito, A Gasbarrini
Gut pathogens 5, 1-8, 2013
8302013
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori
A Gasbarrini, F Franceschi, R Tartaglione, R Landolfi, P Pola, ...
The Lancet 352 (9131), 878, 1998
7751998
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G Cammarota, L Masucci, G Ianiro, S Bibb˛, G Dinoi, G Costamagna, ...
Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015
6612015
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
A Santoro, L Rimassa, I Borbath, B Daniele, S Salvagni, JL Van Laethem, ...
The lancet oncology 14 (1), 55-63, 2013
6552013
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ...
Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006
6552006
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
P Malfertheiner, F Megraud, T Rokkas, JP Gisbert, JM Liou, C Schulz, ...
Gut 71 (9), 1724-1762, 2022
636*2022
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
F Cremonini, S Di Caro, EC Nista, F Bartolozzi, G Capelli, G Gasbarrini, ...
Alimentary pharmacology & therapeutics 16 (8), 1461-1467, 2002
6342002
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: the RELIEF trial
R Ba˝ares, F Nevens, FS Larsen, R Jalan, A Albillos, M Dollinger, ...
Hepatology 57 (3), 1153-1162, 2013
6332013
Extraintestinal manifestations in inflammatory bowel disease
S Danese, S Semeraro, A Papa, I Roberto, F Scaldaferri, G Fedeli, ...
World journal of gastroenterology 11 (46), 7227, 2005
5912005
Antibiotics as deep modulators of gut microbiota: between good and evil
G Ianiro, H Tilg, A Gasbarrini
Gut 65 (11), 1906-1915, 2016
5862016
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review
G Cammarota, G Ianiro, A Gasbarrini
Journal of clinical gastroenterology 48 (8), 693-702, 2014
5792014
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development
MA Zocco, E Di Stasio, R De Cristofaro, M Novi, ME Ainora, F Ponziani, ...
Journal of hepatology 51 (4), 682-689, 2009
5752009
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placeboá…
A Tursi, G Brandimarte, A Papa, A Giglio, W Elisei, GM Giorgetti, G Forti, ...
Official journal of the American College of Gastroenterology| ACG 105 (10á…, 2010
5612010
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference
A Parodi, A Colecchia, PS Orsola-Malpighi, D Festi, F Perri
Aliment. Pharmacol. Ther 29, 1-49, 2009
5572009
Food components and dietary habits: keys for a healthy gut microbiota composition
E Rinninella, M Cintoni, P Raoul, LR Lopetuso, F Scaldaferri, G Pulcini, ...
Nutrients 11 (10), 2393, 2019
5492019
The system can't perform the operation now. Try again later.
Articles 1–20